RE: Great Results with more news to come15 Sep 2020 09:40
Quick glance through the results suggests all is going to plan, revenue's slightly down but cash equivalents up, and no right downs so posting a profit, several new contracts signed.
No major breakthrough news with approval of generic Advair® programme (VR315 (US)), partnered with Hikma, in H2 2020 still in waiting, and the GSK issue still to be fully resolved, both of these issues will be positive if they go VECs way.
All in all its looks positive going forwards.